Metformin Triggers Ferroptosis in AML Through Lipid Remodeling: A Repurposing Opportunity for Metabolic Subtypes
Highlight
– Metformin induces reactive oxygen species (ROS) and ferroptotic cell death in primary AML samples ex vivo, with greatest effect in cases having disrupted lipid metabolism (notably IDH2- and FLT3-mutant disease).
– Lipidomic remodeling with increased triglycerides and polyunsaturated fatty acids (PUFAs), upregulation of lipid-droplet genes including DGAT1, and CD36-mediated uptake are key determinants of metformin sensitivity.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.